Nicholas Huntington leads quite the compelling double life. By day, he is a research professor at Monash University in Melbourne, heading the Cancer Immunotherapy Laboratory within the Biomedicine Discovery Institute. As an international leader in Natural Killer (NK) cell biology, he has driven cutting‐edge research on IL‑15 signaling, NK cell checkpoints such as Cish, and transcriptional regulators like IKAROS—breakthroughs that have wide relevance for cancer therapy
By night, he dons a different hat as co‑founder and Chief Scientific Officer of AUDAX Pty Ltd, a Melbourne‑based biotech company developing immune modulating agents for oncology and autoimmunity.
This dual identity positions him uniquely at the interface of academic discovery and entrepreneurial translation in Australia.